This compound is a brominated benzodiazepine derivative used as a reference standard for impurity testing in pharmaceutical manufacturing. It is a chemical compound with a heterocyclic structure containing amide and aromatic ring systems.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 868350-97-4
11-?Chloro-?N-?methyl-?2-?phenyl-?3-?oxa-?4,?7-?diazatricyclo[6.4.0.?0{2,?4}?]?dodeca-?1(12)?,?6,?8,?10-?tetraen-?6-?amine
pharmaceutical raw material
8-Chloro-6-(2-fluorophenyl)-1-methyl-3a,4-dihydro-3H-imidazo[1,5-a][1,4]benzodiazepine
pharmaceutical raw material
Ethyl 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
pharmaceutical raw material
Carfilzomib
pharmaceutical raw material
S-(5'-Adenosyl)-L-methionine chloride dihydrochloride
pharmaceutical raw material
Halofuginone
pharmaceutical raw material
Umeclidinium bromide
pharmaceutical raw material
Methyl (S)-3-(7-bromo-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)propanoate
research compound
7-bromo-5-(6-methyl-2-pyridinyl)-1,3-dihydro-1,4-benzodiazepin-2-one
QZOXQUQNSNCNFD-UHFFFAOYSA-N
CC1=NC(=CC=C1)C2=NCC(=O)NC3=C2C=C(C=C3)Br